Back to results
US 12,692,491 B2Granted
Nucleic acid complexes for screening barcoded compounds
AssigneeChildren's Medical Center Corporation
InventorsWesley Philip Wong, Clinton H. Hansen
Life of this patent
Estimating the term…
Abstract
The invention provides compositions comprising nucleic acid complexes for use in screening compounds based on their ability to modulate binding interactions, wherein the compounds are barcoded.
Claims19
A method comprising
- contacting (1) a nucleic acid complex conjugated to a first binding partner and a second binding partner with (2) a candidate ligand conjugated to a nucleic acid barcode,
- isolating a nucleic acid complex having the first binding partner bound to (a) the second binding partner and (b) the candidate ligand, and
- identifying the candidate ligand bound to the first binding partner by nucleic acid sequencing of the nucleic acid barcode,
- wherein the nucleic acid complex comprises a single-stranded scaffold nucleic acid hybridized to a plurality of single-stranded oligonucleotides, wherein a first single-stranded oligonucleotide in the plurality is linked to the first binding partner and a second single-stranded oligonucleotide in the plurality is linked to the second binding partner, and
- wherein the first binding partner and the second binding partner do not bind to each other unless the candidate ligand is bound to the first binding partner.
2 more elements
A method comprising
- contacting (1) a plurality of nucleic acid complexes each conjugated to a first binding partner and a second binding partner with (2) a plurality of candidate ligands each conjugated to a distinct/unique nucleic acid barcode,
- physically separating (1) nucleic acid complexes having the first binding partner bound to the second binding partner and to the candidate ligand from (2) other nucleic acid complexes, and
- identifying the candidate ligand bound to the first binding partner by nucleic acid sequencing of the nucleic acid barcode,
- wherein each nucleic acid complex comprises a single-stranded scaffold nucleic acid hybridized to a plurality of single-stranded oligonucleotides, wherein a first single-stranded oligonucleotide in the plurality is linked to the first binding partner and a second single-stranded oligonucleotide in the plurality is linked to the second binding partner,
- wherein the first binding partner and the second binding partner do not bind to each other unless the candidate ligand is bound to the first binding partner.
2 more elements
A method comprising
- contacting a target with a candidate ligand conjugated to a nucleic acid barcode, wherein the target and optionally the candidate ligand are bound to a nucleic acid complex that is further bound to an active-target-specific binding partner and an inactive-target-specific binding partner,
- isolating a target bound to a candidate ligand and an active-target-specific binding partner, and
- identifying the candidate ligand bound to the target by nucleic acid sequencing of the nucleic acid barcode,
- wherein the nucleic acid complex comprises a single-stranded scaffold nucleic acid hybridized to a plurality of single-stranded oligonucleotides, wherein a first single-stranded oligonucleotide is linked to the target and a second single-stranded oligonucleotide is linked to the active-target-specific binding partner,
- wherein the target does not bind to the active-target-specific binding partner in the absence of the candidate ligand.
2 more elements
A method comprising
- contacting (1) a nucleic acid complex conjugated to a first binding partner and a second binding partner with (2) a candidate ligand conjugated to a nucleic acid barcode, wherein the first binding partner has affinity for the second binding partner in the absence of the candidate ligand,
- isolating a nucleic acid complex having the first binding partner bound to the candidate ligand and not bound to the second binding partner, and
- identifying the candidate ligand bound to the first binding partner by nucleic acid sequencing of the nucleic acid barcode,
- wherein the nucleic acid complex comprises a single-stranded scaffold nucleic acid hybridized to a plurality of single-stranded oligonucleotides, wherein a first single-stranded oligonucleotide in the plurality is linked to the first binding partner and a second single-stranded oligonucleotide in the plurality is linked to the second binding partner,
- wherein the second binding partner and the candidate ligand are different from each other.
2 more elements
Dependencies are inferred from the claim text.